Hospice agencies sell for 5x to 9x SDE or 8x to 16x EBITDA, measuring earnings before interest, taxes, depreciation, and amortization from patient care revenue and government and insurance reimbursements. Agencies with stable 150+ average daily census, diversified referral sources across 50+ partners, appropriate length of stay patterns, and 90%+ clinical staff retention consistently achieve the upper range. The valuation spread reflects patient census stability, referral source diversity, and clinical team sustainability that buyers evaluate when pricing hospice agency acquisitions.

Average daily census demonstrates core revenue-generating asset and operational scale. A hospice agency with 150 average daily census at $220 daily Medicare reimbursement generates $10.8M annual revenue. Census stability depends on referral source reliability, patient satisfaction, and care quality reputation. Buyer valuations rely on 24-month census trending to project sustainable revenue base and growth trajectory. Agencies with documented 150+ ADC maintained over 24+ months command premium valuations because consistent census demonstrates market position and institutional cash flow.

Diversified referral sources reduce existential dependency on single hospital relationships or physician networks. Agencies deriving referrals from 50+ individual sources including hospitals, skilled nursing facilities, assisted living communities, individual primary care physicians, and community referrals demonstrate broad market penetration and professional reputation. Hospital partnerships generating 20-30% of census provide volume and stability but create dependency risk if partner relationships change due to contracting disputes or consolidation. Skilled nursing facility relationships generating 15-25% of census provide predictable flow from chronic care populations. Primary care physician office relationships and medical groups generating 15-20% of referrals demonstrate community relationships. Community and family referrals from satisfied patients generating 10-15% of census indicate care quality and word-of-mouth reputation. Buyers evaluate referral concentration because diversified sources reduce acquisition risk from any single partnership disruption, similar to customer concentration analysis in our home healthcare business valuation guide.

Length of stay patterns reflect care quality, patient selection appropriateness, and regulatory audit risk. Average length of stay of 45-60 days aligns with Medicare expectations and demonstrates appropriate case selection and clinical judgment. Agencies with average LOS exceeding 90 days may indicate undischarging patients or overly aggressive admission criteria creating Medicare audit risk and potential recoupment liability. Agencies with average LOS below 30 days suggest inadequate pre-admission screening or overly selective admission criteria limiting volume potential. Medicare scrutinizes agencies with LOS patterns deviating significantly from regional benchmarks, typically 50-70 days. Appropriate LOS metrics of 45-60 days demonstrate case management discipline, clinical appropriateness, and regulatory alignment. Buyers evaluate LOS trending over 24+ month periods because appropriate patterns reduce audit risk and demonstrate clinically sound operations.

Regulatory compliance with clean state surveys and zero sanctions demonstrates operational discipline and reduces buyer acquisition risk. Medicare conditions of participation require comprehensive state surveys every three years. Clean survey records with zero deficiencies demonstrate compliance with care standards, documentation requirements, infection control protocols, and staff qualifications. Agencies with history of deficiencies face increased survey frequency and mandatory corrective action plans creating administrative burden and provider morale challenges. CMS may impose sanctions including civil money penalties, service limitations, or provider exclusion for serious violations. Buyers conduct detailed state survey reviews and compliance documentation because clean records reduce regulatory risk. Agencies with five-plus year clean survey records command significant valuation premiums of 20-30% because regulatory risk transfers to buyer.

Medicare Advantage payer mix strategy significantly affects reimbursement rates and financial performance. Traditional Medicare FFS reimbursement averages $210-260 daily per patient. Medicare Advantage plans contract at rates 25-40% above FFS, generating $265-350 daily reimbursement for comparable care delivery. MA plans typically require capitated payment arrangements covering all hospice services for fixed daily rates. Agencies with MA penetration exceeding 35% of census generate 20-30% higher reimbursement margins. MA payer relationships require care coordination with health plan case managers and patient advocacy responsibilities extending beyond traditional Medicare hospice operations. Buyer financial models explicitly evaluate payer mix composition because higher MA reimbursement rates directly improve operating margins and enterprise valuation on 8x-16x multiples.

Stable clinical team retention ensures care quality and reduces training costs. Nurse turnover exceeding 30% annually creates safety concerns and training costs. Agencies with RN retention above 85% and aide retention above 80% demonstrate positive culture and compensation alignment. Nursing salaries average $65K-80K annually in hospice settings. Aide compensation averages $30K-38K annually. Staff stability improves satisfaction scores and clinical outcomes. Buyers evaluate retention metrics because stable teams reduce turnover costs, ensure care quality, and represent institutional value.

Adjusted EBITDA normalizes owner compensation, above-market clinician compensation, and discretionary business expenses. A hospice agency generating $12M annual revenue with $2.4M adjusted EBITDA at 8.5x values at $20.4M. A comparable agency with 180 ADC, diversified referral sources, 40% MA payer mix, and 92% staff retention might command 10x, or $24M—the $3.6M premium reflects operating leverage and risk reduction.

The buyer landscape includes national hospice platforms consolidating regional operators at 8x-12x EBITDA seeking scale efficiency, PE-backed healthcare platforms at 7x-10x building geographic networks, home healthcare companies expanding into hospice at 6x-9x leveraging existing clinical infrastructure, and experienced operators building franchises at 5x-8x. National platforms pay top multiples because acquired agencies integrate into nationwide networks with centralized billing, HR, and compliance infrastructure reducing overhead ratios, comparable to consolidation benefits analyzed in our senior care business valuation guide. Related industries that follow similar consolidation dynamics include Senior Care / Assisted Living and Dental Practice.